Publications

June 9, 2022

EHA – 2022 – Poster Presentation 1429

CD33-CLL1 Treatment System, Platform

Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment